Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Fish Shellfish Immunol ; 31(2): 189-95, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21605687

ABSTRACT

Autophagy is an important cellular response to starvation and stress, and plays critical roles in embryogenesis, development, cell death, cancer, and immunity. Beclin-1 is one of the central regulators of autophagy in mammals. In the present study, we isolated a PoBeclin-1 cDNA from the olive flounder (Paralichthys olivaceus) by screening a flounder gill cDNA library and rapid amplification of cDNA ends (RACE). The PoBeclin-1 cDNA we isolated encodes a 447-amino acid polypeptide containing a conserved Bcl-2-binding domain. The deduced amino acid sequence of PoBeclin-1 showed high degrees of sequence identity (80.5-95.3%) with Beclin-1 from human, frog, mouse, zebrafish, and pufferfish. PoBeclin-1 transcripts were detected from 1 day post-hatching and were found to be ubiquitously expressed in the healthy flounder. Expression of PoBeclin-1 mRNA was increased in the kidney and spleen of flounders challenged with viral hemorrhagic septicemia virus (VHSV). When infected with VHSV, PoBeclin-1-overexpressing HINAE cells had low level (about 26%) of VHSV G transcripts compared to control cells. Taken together, these results suggest that PoBeclin-1 may play a role in the innate immune response to viral infection in the flounder.


Subject(s)
Apoptosis Regulatory Proteins/metabolism , Fish Proteins/metabolism , Flounder/genetics , Flounder/immunology , Novirhabdovirus , Amino Acid Sequence , Animals , Apoptosis Regulatory Proteins/chemistry , Apoptosis Regulatory Proteins/genetics , Autophagy , Base Sequence , Cloning, Molecular , DNA, Complementary/genetics , DNA, Complementary/immunology , Fish Proteins/chemistry , Fish Proteins/genetics , Flounder/metabolism , Flounder/virology , Gene Expression Regulation , Molecular Sequence Data , Phylogeny , RNA, Messenger/genetics , Rhabdoviridae Infections/immunology , Rhabdoviridae Infections/veterinary , Rhabdoviridae Infections/virology , Sequence Alignment
2.
Biochem Biophys Res Commun ; 339(3): 1007-14, 2006 Jan 20.
Article in English | MEDLINE | ID: mdl-16325779

ABSTRACT

Macrophages participate in several inflammatory pathologies such as sepsis and arthritis. We examined the effect of simvastatin on the LPS-induced proinflammatory macrophage RAW264.7 cells. Co-treatment of LPS and a non-toxic dose of simvastatin induced cell death in RAW264.7 cells. The cell death was accompanied by disruption of mitochondrial membrane potential (MMP), genomic DNA fragmentation, and caspase-3 activation. Surprisingly, despite caspase-dependent apoptotic cascade being completely blocked by Z-VAD-fmk, a pan-caspase inhibitor, the cell death was only partially repressed. In the presence of Z-VAD-fmk, DNA fragmentation was blocked, but DNA condensation, disruption of MMP, and nuclear translocation of apoptosis inducing factor were obvious. The cell death by simvastatin and LPS was effectively decreased by both the FPP and GGPP treatments as well as mevalonate. Our findings indicate that simvastatin triggers the cell death of LPS-treated RAW264.7 cells through both caspase-dependent and -independent apoptotic pathways, suggesting a novel mechanism of statins for the severe inflammatory disease therapy.


Subject(s)
Apoptosis/physiology , Lipopolysaccharides/administration & dosage , Macrophage Activation/physiology , Macrophages/drug effects , Macrophages/metabolism , Signal Transduction/physiology , Simvastatin/administration & dosage , Animals , Apoptosis/drug effects , Caspases/metabolism , Cell Line , Dose-Response Relationship, Drug , Macrophage Activation/drug effects , Mice , Signal Transduction/drug effects
3.
Anticancer Drugs ; 16(5): 507-13, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15846116

ABSTRACT

Previous studies have demonstrated that N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), a well-known DNA alkylating agent, induces G2/M arrest and apoptotic cell death in several human cancer cell lines. In the present study, we investigated the effects of MNNG on the growth of a U937 human leukemia cell model. The effects of this compound were also tested on cyclooxygenase (COX) activity. Treatment of U937 cells with MNNG resulted in the inhibition of viability and the induction of apoptosis in a concentration-dependent manner, which was associated with a dose-dependent upregulation in pro-apoptotic Bax protein, downregulation of anti-apoptotic Bcl-2 and Bcl-xL proteins, and proteolytic activation of caspase-3 protease. Furthermore, MNNG decreased the levels of COX-2 mRNA and protein expression without significant changes in the levels of COX-1, which was correlated with inactivation of the reporter construct of a COX-2 promoter and decrease in prostaglandin E2 synthesis. Taken together, these findings provide important new insights into the possible molecular mechanisms of the anti-cancer activity of MNNG.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cyclooxygenase Inhibitors/pharmacology , Methylnitronitrosoguanidine/pharmacology , Prostaglandin-Endoperoxide Synthases/metabolism , Caspase 3 , Caspases/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Cyclooxygenase 1 , Cyclooxygenase 2 , Cyclooxygenase 2 Inhibitors , Dinoprostone/metabolism , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Humans , Leukemia , Membrane Proteins , Proto-Oncogene Proteins/biosynthesis
4.
Int J Oncol ; 25(4): 1081-7, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15375559

ABSTRACT

In macrophages, nuclear factor kappa B (NF-kappaB) activation has important roles for the regulation of an inducible nitric oxide synthase (iNOS), several pro-inflammatory cytokines, and anti-apoptotic proteins. In order to analyze the transactivation process of NF-kappaB by lipopolysaccharide (LPS), we used the GAL4-NF-kappaB-p65 fusion protein. This chimeric NF-kappaB is activated transcriptionally only if NF-kappaB transactivation domain is active. With this system, we found that LPS can enhance the transactivation of GAL-NF-kappaB-p65 subunit independent of DNA binding ability and inhibitor of kappaB (IkappaB) regulation. Interestingly, this transactivation by LPS was eliminated with the treatment of U0126, specific inhibitor of mitogen-activated protein kinase (MAPK) kinases (MEKs) 1/2 which has little effect on NF-kappaB activation. We also investigated the effect of inhibitors of apoptosis (IAPs), which might be involved in LPS responses and c-Jun amino terminal kinase (JNKs) activation, on the transactivation of GAL-NF-kappaB-p65. The cIAP1, cIAP2 and XIAP could enhance the NF-kappaB transcription and the chimeric NF-kappaB-p65 transactivation. However, survivin decreased the NF-kappaB transcription and did not influence significantly the chimeric NF-kappaB-p65 transactivation. Taken together, LPS-dependent NF-kappaB transactivation may be involved in extracellular signal-regulated kinase (ERK) pathway and IAPs.


Subject(s)
Lipopolysaccharides/pharmacology , NF-kappa B/physiology , Transcriptional Activation/drug effects , Animals , Baculoviral IAP Repeat-Containing 3 Protein , Cell Line , Inhibitor of Apoptosis Proteins , MAP Kinase Signaling System , Macrophages/metabolism , Mice , Mitogen-Activated Protein Kinase 1/physiology , Mitogen-Activated Protein Kinase 3/physiology , Nitric Oxide/biosynthesis , Peptides/pharmacology , Proteins/physiology , Sulindac/pharmacology , Transcription Factor RelA , Ubiquitin-Protein Ligases
5.
Biochem Biophys Res Commun ; 321(2): 298-305, 2004 Aug 20.
Article in English | MEDLINE | ID: mdl-15358175

ABSTRACT

Nitric oxide (NO) is involved in many physiological processes and also causes pathological effects by inducing apoptosis. It can enhance or suppress apoptosis depending on its concentration and the cell type involved. In this report, we used cDNA microarray analysis to show that SNAP, an NO donor, strongly induces Bcl-2/adenovirus E1B 19kDa-interacting protein 3 (BNIP3) in macrophages. BNIP3 is a mitochondrial pro-apoptotic protein that contains a Bcl-2 homology 3 domain and a COOH-terminal transmembrane (TM) domain. Macrophages activated by LPS/IFN-gamma produce nitric oxide synthase 2 (NOS2) and release endogenous NO. Expression of BNIP3 was also induced in macrophages by LPS/IFN-gamma, and the induction was blocked by a NOS2 inhibitor, S-methyl-isothiourea. Peritoneal macrophages from NOS2-null mice failed to produce BNIP3 in response to LPS/IFN-gamma. We conclude that BNIP3 expression in macrophages is controlled by the intracellular level of nitric oxide. Overexpression of BNIP3 but not of BNIP3 deltaTM, a BNIP3 mutant without the TM domain and C-terminal tail, led to apoptosis of the cells. Promoter analysis showed that the region between -281 and -1 of the 5'-upstream enhancer region of murine BNIP3 was sufficient for NO-dependent expression of BNIP3.


Subject(s)
Apoptosis , Gene Expression Regulation , Macrophages, Peritoneal/cytology , Macrophages, Peritoneal/metabolism , Membrane Proteins/genetics , Nitric Oxide/metabolism , Proto-Oncogene Proteins/genetics , Animals , Apoptosis/drug effects , Cell Line , Gene Deletion , Gene Expression Regulation/drug effects , Interferon-gamma/pharmacology , Lysophospholipids/pharmacology , Macrophages, Peritoneal/drug effects , Mice , Mice, Knockout , Nitric Oxide Synthase/deficiency , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , Promoter Regions, Genetic/genetics , Proto-Oncogene Proteins c-bcl-2/genetics , S-Nitroso-N-Acetylpenicillamine/pharmacology , Transcription, Genetic/drug effects , Transcription, Genetic/genetics
6.
Biochem Biophys Res Commun ; 317(2): 558-64, 2004 Apr 30.
Article in English | MEDLINE | ID: mdl-15063794

ABSTRACT

Macrophages activated by microbial lipopolysaccharides (LPS) produce bursts of nitric oxide and reactive oxygen species (ROS). Redox protection systems are essential for the survival of the macrophages since the nitric oxide and ROS can be toxic to them as well as to pathogens. Using suppression subtractive hybridization (SSH) we found that cytosolic NADP(+)-dependent isocitrate dehydrogenase (IDPc) is strongly upregulated by nitric oxide in macrophages. The levels of IDPc mRNA and of the corresponding enzymatic activity were markedly increased by treatment of RAW264.7 cells or peritoneal macrophages with LPS or SNAP (a nitric oxide donor). Over-expression of IDPc reduced intracellular peroxide levels and enhanced the survival of H2O2- and SNAP-treated RAW264.7 macrophages. IDPc is known to generate NADPH, a cellular reducing agent, via oxidative decarboxylation of isocitrate. The expression of enzymes implicated in redox protection, superoxide dismutase (SOD) and catalase, was relatively unaffected by LPS and SNAP. We propose that the induction of IDPc is one of the main self-protection mechanisms of macrophages against LPS-induced oxidative stress.


Subject(s)
Isocitrate Dehydrogenase/metabolism , Lipopolysaccharides/pharmacology , Macrophages/cytology , Macrophages/metabolism , Nitric Oxide/metabolism , Reactive Oxygen Species/metabolism , S-Nitroso-N-Acetylpenicillamine/pharmacology , Animals , Cell Survival/drug effects , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...